Author

Nicolas Oltean

NYU Langone’s Laura and Isaac Perlmutter Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anika Hashem· 1 shared Beatrix M. UeberheideiD· 1 shared Evgeny KanshiniD· 1 shared Michelle KrogsgaardiD· 1 shared Samantha NyovanieiD· 1 shared Y. PatskovskyiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anika Hashem

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

FGL-1 binding to LAG-3 inhibits T cell activation via disruption of CD28 and TCR signaling

Samantha Nyovanie, Anika Hashem, Evgeny Kanshin, Nicolas Oltean, Beatrix M. Ueberheide, Y. Patskovsky, Michelle Krogsgaard

This study shows FGL-1 binding to LAG-3 inhibits T cell activation by disrupting CD28 and TCR signaling through Lck mislocalization and reduced phosphorylation.

bioRxiv · Aug 5, 2025 · PreprintImmunology